'Unsustainable' Drug Pricing Requires 'Global Solution'
This article was originally published in Scrip
The pricing situation in the US is "completely unsustainable," according to Express Scripts CMO Steve Miller. Of course, this isn't a uniquely US issue, but with more than half of global pharma industry profits coming out of the US, "patients feel they're bearing the brunt of the cost of innovation," he told delegates at the FT Global Pharmaceutical and Biotechnology Conference in London (Nov. 16).
Register for our free email digests: